Koumas, C., & Michelassi, F. (2024). Immune-Mediated Necrotizing Myopathies: Current Landscape. Current Neurology and Neuroscience Reports, 24(5), 141–150. https://doi.org/10.1007/s11910-024-01337-y

Tavee, J., Brannagan, T. H., Lenihan, M. W., Muppidi, S., Kellermeyer, L., & D Donofrio, P. (2023). Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee. Muscle & Nerve, 68(4), 356–374. Portico. https://doi.org/10.1002/mus.27922

Hasan, G., Ferucci, E. D., Buyon, J. P., Belmont, H. M., Salmon, J. E., Askanase, A., Bathon, J. M., Geraldino-Pardilla, L., Ali, Y., Ginzler, E. M., Putterman, C., Gordon, C., Helmick, C. G., Parton, H., & Izmirly, P. M. (2022). Population-based prevalence and incidence estimates of mixed connective tissue disease from the Manhattan Lupus Surveillance Program. Rheumatology, 62(8), 2845–2849. https://doi.org/10.1093/rheumatology/keac703

Suresh, S. C., Hasan, A., Zonnoor, S. L., Anziska, Y., Christopher-Stine, L., Tanji, K., & Kabani, N. (2023). Can IgG4-related disease present as isolated myositis? Neuromuscular Disorders, 33(7), 570–574. https://doi.org/10.1016/j.nmd.2023.04.004